Formulary Search
A to Z of Drugs : E
Records returned : 129 (on 29 May 2025 at 01:07:06).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Pessaries
- Vaginal cream
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care.
Reserved for use where apixaban / rivaroxaban are not suitable
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Tensilon test for diagnosis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not 1st line.
Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Haematology use only - treating chronic immune thrombocytopenia as per NICE TA293.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to Empagliflozin initiation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Reserve combination products for patients in whom separate components are less appropriate.
Existing patients would not be expected to change therapy unless appropriate to do so.
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Pre-exposure prophylaxis (PrEP) is available through Sexual Health clinics for people at risk. Use as recommended by BHIVA/BASHH guidelines
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Only licensed for use in children.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred ACE inhibitor during breastfeeding (where an ACE inhibitor is appropriate)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribe by brand.
RSCH / SASH / ASPH = Inhixa brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribe by brand.
RSCH / SASH / ASPH = Inhixa brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribe by brand.
RSCH / SASH / ASPH = Inhixa brand
Formulary Status :
Links :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand
Specialist initiation and at least one month supply before transfer to primary care (excluding obstetric and cancer patients)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use.
Prescribe by brand:
RSCH / SASH / ASPH = Inhixa brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred COMT inhibitor
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
RESTRICTED - requires Hepatologist Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Hypotentsion reversal in spinal or epidural anaesthesia
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation restricted to cardiology. Transfer to primary care only after initiation and at least the first month supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Heamatology team only.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Heamatology team only.
RSFT and ASPH preferred product is Epoetin Zeta.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Heamatology team only.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts.
Symptomatic anaemia in MDS or chronic renal failure, adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Off-label use. For ITU administration via Aerogen nebuliser system.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ITU use only - during renal dialysis if heparin is not suitable
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ITU use only - in patients too unstable for transfer to tertiary care.
Not for routine use - commissioned by NHSE from specialist centres only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not licensed for this indication - refer to guidelines for alternatives
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Empagliflozin is the preferred SGLT-2.
Ertugliflozin is a treatment option.
Trusts restrict to diabetic team initiation only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Subject to NICE TA854
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only when 1st-line and 1st-line adjunctive agents have been unsuccessful
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Intravenous infusion
Restrictions / Comments:
Important
Restricted to cardiology / Theatres / ITU / Resus
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Lansoprazole capsules are the preferred option.
Esomeprazole 40mg restricted to short-term use or for Zollinger-Ellison syndrome.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Granules
Restrictions / Comments:
Important
Lansoprazole oro-dispersible 1st-line. Esomeprazole is 3rd-line. Restricted to patients with swallowing difficulties or with large bore enteral feeding tube when other options are not clinically appropriate. Do not use in tubes less than 6F.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Granules
Restrictions / Comments:
Important
Branded Nexium granules for children/infants with enteral feeding tubes (6Fr or larger). Off-label use in infants under 1 year.
Generic granules 3rd line in children/infants under 1 year without an NG tube. Refer to PPI algorithm for details.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Elleste Solo tablets - 1st line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Estradiol patches 2nd line to tablets. No preferred patch recommendation has been made due to current stock shortages (Estraderm, Estradot, Evorel, FemSeven, Progynova TS)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
Lenzetto spray. Caution with higher than licensed doses. Max supply of 20 containers per year to stay within licensed dose.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Oestrogel is the preferred gel option. Sandrena is an alternative option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Progynova and Zumenon tablets NOT 1st line. Only prescribe where Elleste Solo tablets are unavailable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Gel
- Patches
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal tablets
Restrictions / Comments:
Important
Prescribe 10mcg vaginal tablets generically
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal ring
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Femoston tablets - 1st line for women requiring sequential combined therapy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Femoston Conti - 1st line for women requiring continuous combined therapy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Femseven Conti patches - less preferred. Only use in the event of product shortages.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Tridestra tablets - consider changing to a newer, 1st or 2nd line option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Indivina tablets - consider changing to a newer, 1st or 2nd line option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Evorel Sequi patches 2nd-line. Preferred option in women with risk factors for VTE or migraine.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Elleste Duet tablets 2nd line. For women requiring sequential combined therapy but with poor cycle control on Femoston (1st-line).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Novofem tablets - Only use if there are product shortages with Elleste Duet
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Elleste Duet Conti - 2nd line for women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Evorel Conti patches - preferred in women with risk factors for VTE or migraine. Otherwise use a 1st-line oral option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Kliofem tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Kliovance tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Trisequens tablets - consider changing to newer, 1st or 2nd line options.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Bijuve capsules - 1st line for women requiring continuous combined therapy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal cream
Restrictions / Comments:
Important
Estriol vaginal cream 0.1%
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal gel
Restrictions / Comments:
Important
Estriol (Blissel) vaginal gel is reserved for women who do not tolerate estriol vaginal cream or estradiol pessaries
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal cream
Restrictions / Comments:
Important
Estriol vaginal cream 0.01% is non-formulary
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Vaginal tablets
Restrictions / Comments:
Important
Estriol 500mcg vaginal tablets are non-formulary.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Estriol pessaries (Imvaggis) are non-formulary.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Unlicensed. Short term use for menorrhagic blood loss.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Prescribe by brand.
ICB commissioned in patients after 18 years of age
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Prescribe by brand.
NHSE commissioned in patients under 18 years of age
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Fomepizole is the treatment of choice for ethylene glycol and methanol (methyl alcohol) poisoning. If necessary, ethanol (by mouth or by intravenous infusion) can be used, but with caution.
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
To treat relapsing symptomatic benign cystic, and predominantly cyctic thyroid nodules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Preferred brands: Gedarel 20/150, Bimezza
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Mercilon
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Preferred brands: Millinette 20/75
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Sunya, Akizza 75/20
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Femodette
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Preferred brands = Levest, Rigevidon, Maexeni,
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Microgynon 30 ED, TriRegol, Logynon, Logynon ED
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Ovranette / Ambelina / Microgynon 30 - not for new initiations. Existing patients may remain on current brand.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Elevin brand is not a cost effective option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
For absence, atypical and myoclonic seizures
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Acute gout, gouty arthritis
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line COXX II except for gouty arthritis where etoricoxib is the preferred COX II
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Ulcerative colitis only
NICE guidance applies to Ulcerative Colitis patients only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
NHSE Specialist Commissioned centres only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
NHSE Specialist Commissioned centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Restricted to lipidologists only for heterozygous familial and non-familial hypercholesterolaemia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
1st month supply from specialist team before request for primary care prescribing
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Exenatide is not a preferred treatment option. The preferred GLP-1 for WEEKLY injection is dulaglutide.
Prescribing may continue on existing patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :